Synthelabo S.A. – Trademark Portfolio

Entity Type: 03

Synthelabo S.A. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 2 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include DEXTRALIP. The owner is based in Paris.

58 rue de la Glaciere

Paris 75013 , FR

4 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

MAXERAN
MAXERAN
Abandoned 1996
MAXERAN
MAXERAN
Abandoned 1995
DEXTRALIP
DEXTRALIP
Registered 1982

Trademark Classifications

Synthelabo S.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

1
Chemicals (2 filings)

Chemical products for industry, science, photography, agriculture, horticulture and forestry

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does Synthelabo S.A. have?

Synthelabo S.A. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 abandoned.

What trademark classes does Synthelabo S.A. file in?

Synthelabo S.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.

What are Synthelabo S.A.'s most well-known trademarks?

Synthelabo S.A.'s registered trademark portfolio includes well-known marks such as DEXTRALIP. These are among 1 currently registered trademark in the portfolio.

What is Synthelabo S.A.'s trademark registration success rate?

Synthelabo S.A. has a 25% trademark registration rate, with 1 out of 4 resolved applications resulting in successful registration. Currently, 0 applications are pending review.